MedPath

Sandoz Gmbh

🇨🇷Costa Rica
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.sandoz.at

Clinical Trials

22

Active:18
Completed:4

Trial Phases

2 Phases

Phase 1:12
Phase 3:4

Drug Approvals

153

CIMA_AEMPS:85
EMA:29
NMPA:13
+2 more agencies

Drug Approvals

Penicillin V Potassium Tablets

Product Name
青霉素V钾片
Approval Number
国药准字HJ20140783
Approval Date
Mar 20, 2024
NMPA

Penicillin V Potassium Tablets

Product Name
青霉素V钾片
Approval Number
国药准字HJ20140784
Approval Date
Mar 20, 2024
NMPA

Mirtazapine Tablets

Product Name
米氮平片
Approval Number
国药准字HJ20181172
Approval Date
Jul 29, 2022
NMPA

Mirtazapine Tablets

Product Name
米氮平片
Approval Number
国药准字HJ20181173
Approval Date
Jul 29, 2022
NMPA

Amoxicillin and Clavulanate Potassium Tablets

Product Name
莱得怡
Approval Number
H20150630
Approval Date
May 28, 2020
NMPA

Losartan Potassium tablets/Losartanum kalicum tablets

Product Name
氯沙坦钾片
Approval Number
国药准字J20150076
Approval Date
May 21, 2020
NMPA

Losartan Potassium tablets/Losartanum kalicum tablets

Product Name
氯沙坦钾片
Approval Number
H20140915
Approval Date
Apr 7, 2020
NMPA

Losartan Potassium tablets/Losartanum kalicum tablets

Product Name
氯沙坦钾片
Approval Number
H20140914
Approval Date
Apr 7, 2020
NMPA

Losartan Potassium tablets

Product Name
氯沙坦钾片
Approval Number
H20140913
Approval Date
Apr 7, 2020
NMPA

Penicillin V Potassium Tablets

Product Name
青霉素V钾片
Approval Number
H20140783
Approval Date
May 6, 2019
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Phase 1
12 (75.0%)
Phase 3
4 (25.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.